Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Toripalimab plus Lenvatinib
DRUG
2 trials
Sponsors
Peking Union Medical College Hospital
Conditions
Advanced Biliary Tract Cancer
Hepatocellular Carcinoma
Phase 2
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
NCT04211168
Peking Union Medical College Hospital
Advanced Biliary Tract Cancer
Start: 2020-08-11
End: 2024-12-31
Target: 44
Updated: 2023-03-29
Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma
NCT04368078
Peking Union Medical College Hospital
Hepatocellular Carcinoma
Start: 2020-07-11
End: 2025-04-30
Target: 76
Updated: 2023-03-29